iShares US Pharmaceuticals ETF
IHE
IHE
98 hedge funds and large institutions have $148M invested in iShares US Pharmaceuticals ETF in 2018 Q3 according to their latest regulatory filings, with 16 funds opening new positions, 22 increasing their positions, 30 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
13.83% less ownership
Funds ownership: 111.28% → 97.45% (-14%)
27% less repeat investments, than reductions
Existing positions increased: 22 | Existing positions reduced: 30
Holders
98
Holding in Top 10
–
Calls
$3.56M
Puts
$1.96M
Top Buyers
| 1 | +$4.11M | |
| 2 | +$2.95M | |
| 3 | +$2.06M | |
| 4 |
Jane Street
New York
|
+$1.39M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$1.1M |
Top Sellers
| 1 | -$5.72M | |
| 2 | -$3.29M | |
| 3 | -$2.3M | |
| 4 |
FPGK
Financial Partners Group (Kansas)
Overland Park,
Kansas
|
-$2.14M |
| 5 |
MGIA
Matthew Goff Investment Advisor
Houston,
Texas
|
-$767K |